SIRs for cancer in 1191 patients with SVT
| . | Observed cancers and SIRs (95% CI) . | |||||||
|---|---|---|---|---|---|---|---|---|
| Cancer site . | 0 to <3 months . | 3 to <12 months . | 12+ months . | Overall . | ||||
| Any | 95 | 33 (27-40) | 18 | 2.7 (1.6-4.3) | 70 | 2.1 (1.6-2.6) | 183 | 4.2 (3.6-4.9) |
| Liver | 41 | 1805 (1295-2449) | 5 | 92 (30-215) | 2 | 7.4 (0.9-27) | 48 | 138 (101-182) |
| Myeloproliferative neoplasms | 8 | 764 (329-1505) | 3 | 119 (25-348) | 12 | 88 (45-153) | 23 | 133 (85-200) |
| Pancreas | 17 | 256 (149-409) | 0 | — | 3 | 4.0 (0.8-12) | 20 | 21 (13-32) |
| Hodgkin malignant lymphoma | 1 | 172 (4.3-956) | 0 | — | 0 | — | 1 | 9.7 (0.3-54) |
| Gallbladder or biliary tract | 2 | 132 (16-476) | 1 | 28 (0.7-155) | 0 | — | 3 | 14 (2.9-41) |
| Metastases and nonspecified cancer in lymph nodes | 5 | 86 (28-201) | 0 | — | 0 | — | 5 | 6.3 (2.0-15) |
| MDS | 1 | 75 (1.9-415) | 0 | — | 1 | 6.8 (0.2-38) | 2 | 11 (1.3-38) |
| Kidney | 2 | 47 (5.6-168) | 0 | — | 0 | — | 2 | 3.0 (0.4-11) |
| Leukemia | 2 | 38 (4.6-138) | 0 | — | 1 | 1.7 (0.0-9.3) | 3 | 3.9 (0.8-11) |
| Non-Hodgkin malignant lymphoma | 3 | 34 (7.0-99) | 0 | — | 1 | 0.9 (0.0-5.3) | 4 | 3.0 (0.8-7.5) |
| Lung, bronchi, or trachea | 4 | 13 (3.6-34) | 1 | 1.4 (0.0-8.0) | 7 | 2.0 (0.8-4.2) | 12 | 2.7 (1.4-4.7) |
| Colon | 2 | 9.5 (1.1-34) | 1 | 2.1 (0.1-12) | 3 | 1.3 (0.3-3.8) | 6 | 2.0 (0.7-4.4) |
| Breast | 1 | 3.6 (0.1-20) | 0 | — | 4 | 1.2 (0.3-3.2) | 5 | 1.2 (0.4-2.8) |
| Bladder | 0 | — | 2 | 6.1 (0.7-22) | 6 | 3.8 (1.4-8.3) | 8 | 3.9 (1.7-7.7) |
| Stomach | 0 | — | 1 | 9.8 (0.3-55) | 3 | 6.1 (1.3-18) | 4 | 6.3 (1.7-16) |
| Rectum | 0 | — | 0 | — | 2 | 1.6 (0.2-5.8) | 2 | 1.3 (0.2-4.5) |
| Uterus | 0 | — | 1 | 8.9 (0.2-50) | 0 | 0 | 1 | 1.5 (0.0-8.4) |
| Prostate | 0 | — | 1 | 1.6 (0.0-8.7) | 5 | 1.4 (0.4-3.2) | 6 | 1.3 (0.5-2.9) |
| . | Observed cancers and SIRs (95% CI) . | |||||||
|---|---|---|---|---|---|---|---|---|
| Cancer site . | 0 to <3 months . | 3 to <12 months . | 12+ months . | Overall . | ||||
| Any | 95 | 33 (27-40) | 18 | 2.7 (1.6-4.3) | 70 | 2.1 (1.6-2.6) | 183 | 4.2 (3.6-4.9) |
| Liver | 41 | 1805 (1295-2449) | 5 | 92 (30-215) | 2 | 7.4 (0.9-27) | 48 | 138 (101-182) |
| Myeloproliferative neoplasms | 8 | 764 (329-1505) | 3 | 119 (25-348) | 12 | 88 (45-153) | 23 | 133 (85-200) |
| Pancreas | 17 | 256 (149-409) | 0 | — | 3 | 4.0 (0.8-12) | 20 | 21 (13-32) |
| Hodgkin malignant lymphoma | 1 | 172 (4.3-956) | 0 | — | 0 | — | 1 | 9.7 (0.3-54) |
| Gallbladder or biliary tract | 2 | 132 (16-476) | 1 | 28 (0.7-155) | 0 | — | 3 | 14 (2.9-41) |
| Metastases and nonspecified cancer in lymph nodes | 5 | 86 (28-201) | 0 | — | 0 | — | 5 | 6.3 (2.0-15) |
| MDS | 1 | 75 (1.9-415) | 0 | — | 1 | 6.8 (0.2-38) | 2 | 11 (1.3-38) |
| Kidney | 2 | 47 (5.6-168) | 0 | — | 0 | — | 2 | 3.0 (0.4-11) |
| Leukemia | 2 | 38 (4.6-138) | 0 | — | 1 | 1.7 (0.0-9.3) | 3 | 3.9 (0.8-11) |
| Non-Hodgkin malignant lymphoma | 3 | 34 (7.0-99) | 0 | — | 1 | 0.9 (0.0-5.3) | 4 | 3.0 (0.8-7.5) |
| Lung, bronchi, or trachea | 4 | 13 (3.6-34) | 1 | 1.4 (0.0-8.0) | 7 | 2.0 (0.8-4.2) | 12 | 2.7 (1.4-4.7) |
| Colon | 2 | 9.5 (1.1-34) | 1 | 2.1 (0.1-12) | 3 | 1.3 (0.3-3.8) | 6 | 2.0 (0.7-4.4) |
| Breast | 1 | 3.6 (0.1-20) | 0 | — | 4 | 1.2 (0.3-3.2) | 5 | 1.2 (0.4-2.8) |
| Bladder | 0 | — | 2 | 6.1 (0.7-22) | 6 | 3.8 (1.4-8.3) | 8 | 3.9 (1.7-7.7) |
| Stomach | 0 | — | 1 | 9.8 (0.3-55) | 3 | 6.1 (1.3-18) | 4 | 6.3 (1.7-16) |
| Rectum | 0 | — | 0 | — | 2 | 1.6 (0.2-5.8) | 2 | 1.3 (0.2-4.5) |
| Uterus | 0 | — | 1 | 8.9 (0.2-50) | 0 | 0 | 1 | 1.5 (0.0-8.4) |
| Prostate | 0 | — | 1 | 1.6 (0.0-8.7) | 5 | 1.4 (0.4-3.2) | 6 | 1.3 (0.5-2.9) |